Hydroxocobalamin B12 recalls
The FDA has published 2 recalls involving Hydroxocobalamin B12 since 2022. The latest was reported on 4 May 2022. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 4 May 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why hydroxocobalamin b12 is recalled
Companies
By year
All hydroxocobalamin b12 recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Hydroxocobalamin B12, 1 mg/mL Multi-Dose vial recalled | Olympia Compounding Pharmacy | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS III | Hydroxocobalamin B12 1mg/mL, Multi-Dose vial recalled | Olympia Compounding Pharmacy | Other | Nationwide |
Should you stop taking Hydroxocobalamin B12?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.